ReviewJournal of thoracic disease2024

Farnesoid X receptor (FXR) as a potential therapeutic target for lung diseases: a narrative review.

Yangyang Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.